Zoetis Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $9.5B+2.9% YoYTTM through 30 Jun 2026
Net Income $2.6B+6.1% YoYTTM through 30 Jun 2026
Free Cash Flow $2.3BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 39.7% |
| Operating Margin | 34.6% |
| Net Margin | 27.7% |
Returns
83.8%ROE
17.5%ROA
24.6%ROIC
Balance Sheet Health
Debt / Equity2.87x
Current Ratio3.08x
Net Debt$7.6B
Cash & Equivalents$1.5B
Quality Metrics
Altman Z-Score4.57
Piotroski F-Score6 / 9
FCF Margin24.3%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $9.5B
Diluted EPS$6.13TTMFY2025: $6.02
Dividend
$1.59Per share, FY20262.18%Yield+9.7%5-yr growth
Capital Allocation
Capex Intensity5.5%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| United States | $5.1B | +0.5% | View detailsU.S. segment earnings increased by $102 million, or 3%, in 2025 compared with 2024, primarily due to higher revenue and lower cost of sales, partially offset by higher operating expenses. |
| International | $4.3B | +3.7% | View detailsInternational segment earnings increased by $146 million, or 7%, in 2025 compared with 2024. Operational earnings growth was $106 million, or 5%, primarily due to higher revenue, partially offset by higher cost of sales and operating expenses. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.